Aarti Pharmalabs Limited (AARTIPHARM.BO)
INR 707.1
(-0.88%)
INR 707.1
(-0.88%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.85 Billion INR | 32.99% |
| 2022 | 2.14 Billion INR | -37.11% |
| 2021 | 3.41 Billion INR | 1826175.09% |
| 2020 | 186.75 Thousand INR | 0.0% |
| 2019 | 186.75 Thousand INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 3.73 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 2.85 Billion INR | 32.99% |
| 2023 Q2 | 2.17 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 2.85 Billion INR | 0.0% |
| 2022 FY | 2.14 Billion INR | -37.11% |
| 2022 Q4 | 2.14 Billion INR | -28.57% |
| 2022 Q3 | 3 Billion INR | 0.0% |
| 2021 Q1 | - INR | 0.0% |
| 2021 FY | 3.41 Billion INR | 1826175.09% |
| 2021 Q4 | 3.4 Billion INR | -0.0% |
| 2021 Q3 | 3.4 Billion INR | 0.0% |
| 2021 Q2 | - INR | 0.0% |
| 2020 FY | 186.75 Thousand INR | 0.0% |
| 2019 FY | 186.75 Thousand INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -708.532% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -16404.658% |
| Sigachi Industries Limited | 1.43 Billion INR | -99.403% |
| Bal Pharma Limited | 1.39 Billion INR | -104.263% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -1616.14% |
| Medico Remedies Limited | 80.5 Million INR | -3443.302% |
| Lasa Supergenerics Limited | 220.76 Million INR | -1192.115% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -1563.459% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -366.476% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -293.521% |
| Alpa Laboratories Limited | 52.46 Million INR | -5336.958% |
| NATCO Pharma Limited | 3.71 Billion INR | 23.155% |
| Shilpa Medicare Limited | 9.37 Billion INR | 69.57% |
| Aarti Drugs Limited | 5.64 Billion INR | 49.448% |
| Gufic Biosciences Limited | 3.32 Billion INR | 14.318% |
| Lupin Limited | 29.21 Billion INR | 90.237% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 95.709% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 64.53% |
| FDC Limited | 205.18 Million INR | -1290.209% |
| Windlas Biotech Limited | 36.41 Million INR | -7734.386% |
| Ind-Swift Limited | 10.13 Billion INR | 71.869% |
| Eris Lifesciences Limited | 27.81 Billion INR | 89.744% |
| Indoco Remedies Limited | 6.71 Billion INR | 57.55% |
| Valiant Laboratories Limited | 767.08 Million INR | -271.863% |
| Hester Biosciences Limited | 2.44 Billion INR | -16.725% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 24.469% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 71.799% |
| Ipca Laboratories Limited | 14.38 Billion INR | 80.168% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -185.707% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 91.287% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 14.294% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | -37.687% |
| Laurus Labs Limited | 25.77 Billion INR | 88.933% |
| Piramal Pharma Limited | 47.1 Billion INR | 93.944% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 92.908% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 44.413% |
| Medicamen Biotech Limited | 308.17 Million INR | -825.619% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 76.826% |
| Unichem Laboratories Limited | 2.47 Billion INR | -15.246% |
| Novartis India Limited | 69.7 Million INR | -3992.539% |
| Wanbury Limited | 1.16 Billion INR | -144.882% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -338.87% |
| Wockhardt Limited | 23.56 Billion INR | 87.893% |
| Venus Remedies Limited | 413.3 Million INR | -590.177% |
| Themis Medicare Limited | 957.92 Million INR | -197.78% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -3090.359% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 92.215% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 85.752% |
| Divi's Laboratories Limited | 30 Million INR | -9408.333% |
| Strides Pharma Science Limited | 25.16 Billion INR | 88.666% |
| Procter & Gamble Health Limited | 95.6 Million INR | -2883.787% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 55.117% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -6103.514% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -47.47% |
| Granules India Limited | 13.15 Billion INR | 78.309% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -770.726% |
| Suven Life Sciences Limited | 7.09 Million INR | -40093.039% |
| Hikal Limited | 8.17 Billion INR | 65.11% |
| Sequent Scientific Limited | 4.87 Billion INR | 41.51% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -64892.026% |
| Brooks Laboratories Limited | 56.41 Million INR | -4955.921% |
| Megasoft Limited | 1.47 Billion INR | -93.986% |
| ZIM Laboratories Limited | 1.08 Billion INR | -162.12% |
| Alkem Laboratories Limited | 14.18 Billion INR | 79.889% |
| Neuland Laboratories Limited | 953.89 Million INR | -199.037% |
| Morepen Laboratories Limited | 289.99 Million INR | -883.648% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -801.363% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -189.616% |